| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
248,920,000 |
| Market
Cap: |
20.99(B) |
| Last
Volume: |
1,292,678 |
Avg
Vol: |
1,818,989 |
| 52
Week Range: |
$62.82 - $97.14 |
|
| Level
I Sector: |
Basic Materials |
| Level
II Sector: |
Chemicals |
| Level
III Sector: |
Specialty Chemicals |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 212 |
| Guru Rank Value : 5.8 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile International Flavors & Fragrances is a creator and manufacturer of food, beverage, health and biosciences, scent and pharma solutions and complementary adjacent products. Co.'s business segments are: Nourish, which comprises food ingredients, flavor compounds, and savory solutions and inclusions; Health and Biosciences, which comprises a portfolio of enzymes, food cultures, probiotics and other ingredients for food, home and personal care, and health and wellness applications; Scent, which creates fragrance compounds, fragrance ingredients and cosmetic ingredients and personal care products; and Pharma Solutions, which produces cellulosics and seaweed-based pharma excipients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
1,972 |
13,231 |
| Total Sell Value |
$0 |
$0 |
$170,282 |
$1,580,339 |
| Total People Sold |
0 |
0 |
1 |
2 |
| Total Sell Transactions |
0 |
0 |
1 |
4 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mirzayantz Nicolas |
Group President Fragrance |
• • – |
2021-03-15 |
4 |
D |
$136.79 |
$18,193 |
D/D |
(133) |
32,764 |
|
- |
|
| Mirzayantz Nicolas |
Group President Fragrance |
• • – |
2021-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
389 |
32,897 |
|
- |
|
| Anderson Robert G. |
Controller |
• • – |
2021-03-15 |
4 |
D |
$136.79 |
$5,472 |
D/D |
(40) |
14,108 |
|
- |
|
| Anderson Robert G. |
Controller |
• • – |
2021-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
120 |
14,148 |
|
- |
|
| Herriott Simon |
President Health & Biosciences |
• • – |
2021-02-19 |
4/A |
D |
$139.24 |
$21,582 |
D/D |
(155) |
1,413 |
|
- |
|
| Strzelecki Angela |
President, Pharma Solutions |
• • – |
2021-02-19 |
4 |
D |
$139.24 |
$26,734 |
D/D |
(192) |
691 |
|
- |
|
| Strzelecki Angela |
President, Pharma Solutions |
• • – |
2021-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
584 |
883 |
|
- |
|
| Johnson Jennifer Amy |
EVP, General Counsel |
• • – |
2021-02-19 |
4 |
D |
$139.24 |
$38,569 |
D/D |
(277) |
684 |
|
- |
|
| Johnson Jennifer Amy |
EVP, General Counsel |
• • – |
2021-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
708 |
961 |
|
- |
|
| Herriott Simon |
President Health & Biosciences |
• • – |
2021-02-19 |
4 |
D |
$139.24 |
$26,456 |
D/D |
(190) |
848 |
|
- |
|
| Herriott Simon |
President Health & Biosciences |
• • – |
2021-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
616 |
1,038 |
|
- |
|
| Herriott Simon |
President Health & Biosciences |
• • – |
2021-02-15 |
4/A |
D |
$136.21 |
$3,678 |
D/D |
(27) |
952 |
|
- |
|
| Herriott Simon |
President Health & Biosciences |
• • – |
2021-02-15 |
4 |
D |
$136.21 |
$4,767 |
D/D |
(35) |
422 |
|
- |
|
| Herriott Simon |
President Health & Biosciences |
• • – |
2021-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
105 |
457 |
|
- |
|
| Strzelecki Angela |
President, Pharma Solutions |
• • – |
2021-02-15 |
4 |
D |
$136.21 |
$3,678 |
D/D |
(27) |
299 |
|
- |
|
| Strzelecki Angela |
President, Pharma Solutions |
• • – |
2021-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
81 |
326 |
|
- |
|
| Johnson Jennifer Amy |
EVP, General Counsel |
• • – |
2021-02-15 |
4 |
D |
$136.21 |
$3,269 |
D/D |
(24) |
253 |
|
- |
|
| Johnson Jennifer Amy |
EVP, General Counsel |
• • – |
2021-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
58 |
277 |
|
- |
|
| Herriott Simon |
President Health & Biosciences |
• • – |
2021-02-14 |
4/A |
D |
$136.21 |
$17,980 |
D/D |
(132) |
874 |
|
- |
|
| Herriott Simon |
President Health & Biosciences |
• • – |
2021-02-14 |
4 |
D |
$136.21 |
$23,564 |
D/D |
(173) |
352 |
|
- |
|
| Herriott Simon |
President Health & Biosciences |
• • – |
2021-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
525 |
525 |
|
- |
|
| Strzelecki Angela |
President, Pharma Solutions |
• • – |
2021-02-14 |
4 |
D |
$136.21 |
$16,345 |
D/D |
(120) |
245 |
|
- |
|
| Strzelecki Angela |
President, Pharma Solutions |
• • – |
2021-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
365 |
365 |
|
- |
|
| Johnson Jennifer Amy |
EVP, General Counsel |
• • – |
2021-02-14 |
4 |
D |
$136.21 |
$19,887 |
D/D |
(146) |
219 |
|
- |
|
| Johnson Jennifer Amy |
EVP, General Counsel |
• • – |
2021-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
365 |
365 |
|
- |
|
717 Records found
|
|
Page 5 of 29 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.80 (0.94%) 
